[Cancer screening in Germany: availability and participation]

Area of Science:

• Public Health
• Oncology
• Health Services Research

Background:

• Cancer remains a significant health burden in Germany, with high incidence and mortality rates.
• Early diagnosis is crucial for improving cancer curability and patient prognosis.
• Statutory health services in Germany offer early detection examinations for several common cancers.

Purpose of the Study:

• To describe the current status and participation rates of early cancer detection examinations in Germany.
• To analyze participation in screening for cervical, breast, skin, prostate, and colon cancer.
• To identify areas for improvement in organized cancer screening programs.

Main Methods:

• Analysis of claims data from the statutory health insurance system.
• Inclusion of data from Germany's mammography screening program (MSP).
• Utilization of the "German Health Update" (GEDA 2014/2015-EHIS) survey for self-reported data.

Main Results:

• Participation quotas based on claims data ranged from 16% for colonoscopy to 48% for Pap tests.
• In 2015, 51.5% of women invited to the mammography screening program participated.
• Self-reported participation in the GEDA survey was often substantially higher than claims data indicated.

Conclusions:

• A significant portion of the eligible population utilizes available cancer early detection examinations.
• Expansion of organized, quality-assured screening programs for colon and cervical cancer is planned.
• Future efforts aim to increase participation by providing regular invitations and information on screening benefits and risks.